On Tuesday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) was -1.97% drop from the session before settling in for the closing price of $57.43. A 52-week range for SWTX has been $28.21 – $60.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -25.00%. When this article was written, the company’s average yearly earnings per share was at 40.80%. With a float of $62.04 million, this company’s outstanding shares have now reached $74.34 million.
Let’s determine the extent of company efficiency that accounts for 305 employees. In terms of profitability, gross margin is 93.59%, operating margin of -217.92%, and the pretax margin is -203.09%.
SpringWorks Therapeutics Inc (SWTX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SpringWorks Therapeutics Inc stocks. The insider ownership of SpringWorks Therapeutics Inc is 16.60%, while institutional ownership is 105.69%. The most recent insider transaction that took place on Feb 14 ’25, was worth 2,812,320. Before that another transaction happened on Feb 10 ’25, when Company’s Chief People Officer sold 29,750 for $54.36, making the entire transaction worth $1,617,329. This insider now owns 50,762 shares in total.
SpringWorks Therapeutics Inc (SWTX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 40.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 53.67% during the next five years compared to -65.72% drop over the previous five years of trading.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
You can see what SpringWorks Therapeutics Inc (SWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.73, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -2.03 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Looking closely at SpringWorks Therapeutics Inc (NASDAQ: SWTX), its last 5-days average volume was 4.4 million, which is a jump from its year-to-date volume of 2.65 million. As of the previous 9 days, the stock’s Stochastic %D was 87.13%. Additionally, its Average True Range was 3.71.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 88.36%, which indicates a significant increase from 84.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 127.41% in the past 14 days, which was higher than the 73.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.03, while its 200-day Moving Average is $37.89. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $57.20. Second resistance stands at $58.09. The third major resistance level sits at $59.19. If the price goes on to break the first support level at $55.21, it is likely to go to the next support level at $54.11. Now, if the price goes above the second support level, the third support stands at $53.22.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
There are 74,386K outstanding shares of the company, which has a market capitalization of 4.19 billion. As of now, sales total 5,450 K while income totals -325,100 K. Its latest quarter income was 49,300 K while its last quarter net income were -53,530 K.
